Phoenix Analysis & Design Technologies, Inc. (PADT) and M-Tech Industrial (Pty) Ltd. announced the official launch of PADT as a distributor of the Flownex Simulation Environment in the Southwestern United States. The addition of Flownex to the products and services that PADT already offers broadens the range of solutions that the company can provide to its customers, specifically in the area of system modeling of fluid and thermal systems.Continue reading
Severe budget reductions compelled Northern Arizona University to redefine itself at all levels, which led to a stronger focus on student success and fruitful partnerships, NAU President John Haeger told legislators on Wednesday.Continue reading
BIO is seeking new session proposals containing exciting, fresh information that was not yet known by the original Call for Sessions deadline.
Submit a NEW Late-Breaking Session Proposal February 20 – March 5
The cutting-edge, hot topics are at BIO:Continue reading
1st Total Artificial Heart Patient in Slovenia Discharged from UMC Ljubljana Using the Freedom® Portable Driver
SynCardia Total Artificial Heart was the “Perfect Solution” for Near-Death Patient with Ventricular Septal DefectContinue reading
Ceremony Dedicates Arizona Center for Innovation
The Arizona Center for Innovation was dedicated on Jan. 18 in a ceremony at the UA Tech Park.Continue reading
Where Does Your Future Lie? Perhaps In Your Own Backyard!
Find Out through ARIZONA’s SCITECH Festival – January 25–March 14, 2012Continue reading
The Arizona Commerce Authority (ACA) is pleased to announce its second $1.5 million Arizona Innovation Challenge, the country’s largest monetary award for a technology commercialization challenge.Continue reading
AZBio Fast Lane Award Winner and Leading Social Health Company for Women Partners With the Leader in Health Video to Expand Reach for Its Women’s Health Video Continue reading
The development of a new drug is a long, complicated process involving up to 15 years of research and, in many cases, hundreds of millions of dollars. There are two distinct processes that every drug must go through before reaching the general patient population and treating a specific disease – Drug Discovery and Drug Development.Continue reading
Regenesis Biomedical Expands Payor Sources to Increase Patient Access with addition of a new Reimbursement and Health Economics Vice President and Expands Leadership Team and Market Reach with a new COO.Continue reading